| Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT02778191) | University Medical Center Groningen | 2016-02-01 |
| Bupropion Hydrochloride or Patient's Choice for Smoking Cessation in Patients With Squamous Cell Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy (NCT02582008) | Wake Forest University Health Sciences | 2016-01-01 |
| Chemoprevention of Head and Neck Squamous Cell Carcinoma (HNSCC) With Valproic Acid (NCT02608736) | Barretos Cancer Hospital | 2015-12-01 |
| TumorGraft- Guided Therapy for Improved Outcomes in Head and Neck Squamous Cell Cancer- A Feasibility Study (NCT02752932) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2015-11-01 |
| Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery (NCT02538510) | University of Washington | 2015-10-08 |
| Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC (NCT02639858) | Samyang Biopharmaceuticals Corporation | 2015-10-01 |
| Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC (NCT03070366) | Groupe Oncologie Radiotherapie Tete et Cou | 2015-09-21 |
| Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors (NCT02495896) | University of Southern California | 2015-09-03 |
| Study of SCB01A in Patient With Head and Neck Cancer (NCT02488629) | SynCore Biotechnology Co., Ltd. | 2015-09-01 |
| WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck (NCT02508246) | University of Washington | 2015-07-22 |
| Reactivating NK Cells in Treating Refractory Head and Neck Cancer (NCT02507154) | National University Hospital, Singapore | 2015-07-01 |
| Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT (NCT03340896) | Groupe Oncologie Radiotherapie Tete et Cou | 2015-06-25 |
| Trial of pIL-12 Electroporation in Squamous Cell Carcinoma of the Head and Neck (IL12HNSCC) (NCT02345330) | OncoSec Medical Incorporated | 2015-05-21 |
| Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation (NCT02531906) | Roswell Park Cancer Institute | 2015-04-24 |
| Dual-Energy CT in Patients With Head and Neck Squamous Cell Carcinomas (NCT02279459) | Ottawa Hospital Research Institute | 2015-04-14 |
| Docetaxel and Capecitabine With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT02524275) | University of Nebraska | 2015-03-30 |
| Window Trial 5-aza in HNSCC, T-tare (NCT02178072) | Yale University | 2015-02-19 |
| Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer (NCT02318771) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-02-05 |
| Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (NCT02270814) | Washington University School of Medicine | 2015-02-02 |
| A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor (NCT02365662) | AbbVie | 2015-01-09 |
| Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055) (NCT02255097) | Merck Sharp & Dohme LLC | 2014-10-24 |
| Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC (NCT02268695) | Groupe Oncologie Radiotherapie Tete et Cou | 2014-10-10 |
| Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study (NCT02678884) | University Health Network, Toronto | 2014-10-01 |
| NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab) (NCT01950689) | The Christie NHS Foundation Trust | 2014-09-11 |
| Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck (NCT02207439) | Abramson Cancer Center at Penn Medicine | 2014-07-01 |
| Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence (NCT01824823) | ECOG-ACRIN Cancer Research Group | 2014-06-30 |
| Predictive Value of Diffusion-weighted MRI Performed in Early Post-treatment in the Occurrence of Tumor Recurrence or Progression in Head and Neck Squamous Cell Carcinoma Treated With Chemoradiotherapy: a Pilot Study (NCT02862678) | CHU de Reims | 2014-04-01 |
| A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis (NCT01975688) | GW Pharmaceuticals Ltd | 2014-02-01 |
| The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study (NCT02126189) | Queensland Centre of Excellence for Head and Neck Cancer | 2013-11-01 |
| Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC (NCT01864850) | Groupe Oncologie Radiotherapie Tete et Cou | 2013-10-18 |
| Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy (NCT01852292) | Novartis Pharmaceuticals | 2013-10-01 |
| Phonosurgical Augmentation After Laser Resection of Early Glottic Carcinoma (NCT04525066) | Ayhman Al Afif | 2013-08-13 |
| Immune Response Evaluation to Curative Conventional Therapy (NCT03053661) | University of Ulm | 2013-08-01 |
| Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC (NCT02047201) | Lithuanian University of Health Sciences | 2013-06-01 |
| Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer (NCT01846091) | Mayo Clinic | 2013-04-09 |
| Oral Rigosertib for Squamous Cell Carcinoma (NCT01807546) | Traws Pharma, Inc. | 2013-03-01 |
| Trismus Prevention, Diagnosis and Management: Radiotherapy Planning, Early Detection, and Physical Therapy Intervention (NCT02004639) | Far Eastern Memorial Hospital | 2013-03-01 |
| Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer (NCT01727076) | National Cancer Institute (NCI) | 2013-02-15 |
| Develop and Test the 'Multi-Faced Continuous Exercise Program' in Operable Head and Neck Cancer Patients (NCT05267353) | National Taiwan University Hospital | 2013-01-22 |
| Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer Patients (NCT01941992) | Istituto Oncologico Veneto IRCCS | 2012-12-01 |
| Study on the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family. (NCT01927354) | National Taiwan University Hospital | 2012-12-01 |
| Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IV Head and Neck Cancer (NCT01711541) | National Cancer Institute (NCI) | 2012-10-22 |
| A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract (NCT01697800) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-09-01 |
| DAHANCA 27 Transoral Laser Microsurgery for T1a Glottic Cancer (NCT05289336) | Danish Head and Neck Cancer Group | 2012-09-01 |
| Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery (NCT01696955) | National Cancer Institute (NCI) | 2012-08-20 |
| Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer (NCT01581970) | Masonic Cancer Center, University of Minnesota | 2012-06-01 |
| Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck Cancer (NCT01469546) | University of Michigan Rogel Cancer Center | 2012-01-01 |
| A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT01484847) | University Health Network, Toronto | 2011-12-01 |
| Preoperative Treatment With Cetuximab and/or IMC-A12 (NCT00957853) | M.D. Anderson Cancer Center | 2011-10-17 |
| Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck (NCT01427478) | Centre Leon Berard | 2011-09-01 |
| Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT01377298) | National Taiwan University Hospital | 2011-06-01 |
| Expression & Epigenetic Silencing of MicroRNA for Predicting Therapeutic Response and Prognosis of HPV-negative HNSCC (NCT03953443) | New Mexico Cancer Research Alliance | 2010-12-17 |
| Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT01154920) | M.D. Anderson Cancer Center | 2010-07-09 |
| Efficacy Study of Temsirolimus to Treat Head and Neck Cancer (NCT01172769) | Hannover Medical School | 2010-06-01 |
| Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies (NCT01045421) | Millennium Pharmaceuticals, Inc. | 2010-02-01 |
| Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive Therapy (NCT01794481) | University of Michigan Rogel Cancer Center | 2010-01-01 |
| Profile of Plasma Growth Factors Before and After Head and Neck Oncological or Non-oncological Surgery (NCT01280318) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2009-01-01 |
| Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma (NCT01425736) | Wei Guo | 2009-01-01 |
| 2B or Not 2B? Shoulder Function After Level 2B Neck Dissection: A Randomized Controlled Study (NCT00765791) | University of Alberta | 2008-12-01 |
| Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT00805012) | Seoul National University Hospital | 2008-12-01 |
| Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (NCT01086826) | Associazione Volontari Pazienti Oncologici | 2008-03-01 |
| A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract (NCT00894413) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-05-08 |
| Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma (NCT00634777) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2007-01-01 |
| Prospective Trial of Serial CT Imaging for Evaluation of Dosimetric/Volumetric Changes During IMRT for Head/Neck Cancer (NCT02003482) | University of Miami | 2006-05-09 |
| Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT01515137) | University of Pittsburgh | 2005-11-01 |
| TRACE: Tirapazamine-Radiation And Cisplatin Evaluation (NCT00174837) | Sanofi | 2005-04-01 |
| Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma (NCT00620139) | Memorial Sloan Kettering Cancer Center | 2005-03-01 |